Stock Chart
LLY
$1364.73
-3.76%
Score:
29.1
AVOID NEW MONEY
LEAPs:
SELL
$1500
LEAPs Option Signal
Type: SELL growth_1yr
Strike: $1500
Premium: $163.73
Expiry: Sep 17, 2027
Target: $1385
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Type: SELL growth_1yr
Strike: $1500
Premium: $163.73
Expiry: Sep 17, 2027
Target: $1385
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol:
1.76x
(vs SPY: 0.6x | vs QQQ: 0.6x)
Volume Ratio Explained
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 05, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
About LLY - Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Key Statistics
Market Cap
$FalseT
P/E Ratio
45.74
Dividend Yield
0.00%
More LLY Analysis
This LLY stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track LLY's price movements with trendlines, gamma walls, and key support/resistance levels.